Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Kaolin-based Hemostatic Gauze in Total Knee Arthroplasty

NCT: NCT05504577 · COMPLETED

NCT IDNCT05504577
StatusCOMPLETED
Start Date2022-03-16
Completion2023-10-31
SponsorChang Gung Memorial Hospital (OTHER)
First posted
Last updated

Brief Summary

This study is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of combination of intravenous TXA and QCG in a primary TKA procedure.

Frequently Asked Questions

What is Kaolin-based Hemostatic Gauze in Total Knee Arthroplasty?

Kaolin-based Hemostatic Gauze in Total Knee Arthroplasty is a clinical trial registered under NCT05504577. Current status: COMPLETED.

What is the status of NCT05504577?

The current status of NCT05504577 (Kaolin-based Hemostatic Gauze in Total Knee Arthroplasty) is: COMPLETED.

When did Kaolin-based Hemostatic Gauze in Total Knee Arthroplasty start?

Kaolin-based Hemostatic Gauze in Total Knee Arthroplasty started on 2022-03-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑